38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction
Publication
, Conference
Berry, GE; Asokan, A
Published in: Molecular Therapy
May 2015
Duke Scholars
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S17 / S17
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Berry, G. E., & Asokan, A. (2015). 38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction. In Molecular Therapy (Vol. 23, pp. S17–S17). Elsevier BV. https://doi.org/10.1016/s1525-0016(16)33643-7
Berry, Garrett E., and Aravind Asokan. “38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction.” In Molecular Therapy, 23:S17–S17. Elsevier BV, 2015. https://doi.org/10.1016/s1525-0016(16)33643-7.
Berry GE, Asokan A. 38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction. In: Molecular Therapy. Elsevier BV; 2015. p. S17–S17.
Berry, Garrett E., and Aravind Asokan. “38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction.” Molecular Therapy, vol. 23, Elsevier BV, 2015, pp. S17–S17. Crossref, doi:10.1016/s1525-0016(16)33643-7.
Berry GE, Asokan A. 38. Pharmacological Regulation of Vesicular Trafficking as a Strategy to Enhance Recombinant AAV Transduction. Molecular Therapy. Elsevier BV; 2015. p. S17–S17.
Published In
Molecular Therapy
DOI
ISSN
1525-0016
Publication Date
May 2015
Volume
23
Start / End Page
S17 / S17
Publisher
Elsevier BV
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
- 11 Medical and Health Sciences
- 10 Technology
- 06 Biological Sciences